Effective method for life-style modifications focused on dietary sodium intake in chronic kidney disease: sub-analysis of the FROM-J study.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
26 Aug 2024
Historique:
received: 03 03 2024
accepted: 13 08 2024
medline: 27 8 2024
pubmed: 27 8 2024
entrez: 26 8 2024
Statut: epublish

Résumé

Lifestyle modifications by educational sessions are an important component of multidisciplinary treatment for chronic kidney disease (CKD). We attempted to identify the best method to teach these modifications in order to ensure their acceptance by patients and investigated its effectiveness in CKD practice. This study is a post-hoc analysis of the FROM-J study. Subjects were 876 CKD patients in the advanced care group of the FROM-J study who had received lifestyle modification sessions every 3 months for 3.5 years. Two-hundred and ten males (32.6%) and 89 females (38.2%) showed success in sodium restriction. In this study, we examined factors affecting sodium restriction in these subjects. Subjects received three or more consecutive educational sessions about improvement of salt intake. The median salt-intake improvement maintenance period was 407 days. The number of dietary counseling sessions (OR 1.090, 95%CI: 1.012-1.174) in males and the number of dietary counseling sessions (OR 1.159, 95%CI: 1.019-1.318), CKD stage progression (OR 1.658, 95%CI: 1.177-2.335), and collaboration with a nephrologist (OR 2.060, 95%CI: 1.073-3.956) in females were identified as significant factors improving salt intake. The only factor contributing to the maintenance of improved salt intake was the continuation of dietary counseling (p = 0.013). An increased number of educational sessions was the only successful approach for males to implement and maintain an improved salt intake. Providing the resources for continuous counseling is beneficial for lifestyle modifications and their maintenance in the long-term management of CKD. Continuous counseling for lifestyle modifications is highly cost-effective. The FROM-J study was registered in UMIN000001159 on 16/05/2008.

Sections du résumé

BACKGROUND BACKGROUND
Lifestyle modifications by educational sessions are an important component of multidisciplinary treatment for chronic kidney disease (CKD). We attempted to identify the best method to teach these modifications in order to ensure their acceptance by patients and investigated its effectiveness in CKD practice.
METHODS METHODS
This study is a post-hoc analysis of the FROM-J study. Subjects were 876 CKD patients in the advanced care group of the FROM-J study who had received lifestyle modification sessions every 3 months for 3.5 years. Two-hundred and ten males (32.6%) and 89 females (38.2%) showed success in sodium restriction. In this study, we examined factors affecting sodium restriction in these subjects.
RESULTS RESULTS
Subjects received three or more consecutive educational sessions about improvement of salt intake. The median salt-intake improvement maintenance period was 407 days. The number of dietary counseling sessions (OR 1.090, 95%CI: 1.012-1.174) in males and the number of dietary counseling sessions (OR 1.159, 95%CI: 1.019-1.318), CKD stage progression (OR 1.658, 95%CI: 1.177-2.335), and collaboration with a nephrologist (OR 2.060, 95%CI: 1.073-3.956) in females were identified as significant factors improving salt intake. The only factor contributing to the maintenance of improved salt intake was the continuation of dietary counseling (p = 0.013).
CONCLUSION CONCLUSIONS
An increased number of educational sessions was the only successful approach for males to implement and maintain an improved salt intake. Providing the resources for continuous counseling is beneficial for lifestyle modifications and their maintenance in the long-term management of CKD. Continuous counseling for lifestyle modifications is highly cost-effective.
TRIAL REGISTRATION BACKGROUND
The FROM-J study was registered in UMIN000001159 on 16/05/2008.

Identifiants

pubmed: 39187778
doi: 10.1186/s12882-024-03707-7
pii: 10.1186/s12882-024-03707-7
doi:

Substances chimiques

Sodium, Dietary 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

274

Informations de copyright

© 2024. The Author(s).

Références

Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82.
doi: 10.1016/S0140-6736(14)61601-9 pubmed: 25777665
Huijben JA, Kramer A, Kerschbaum J, de Meester J, Collart F, Arevalo OLR, et al. Increasing numbers and improved overall survival of patients on kidney replacement therapy over the last decade in Europe: an ERA Registry study. Nephrol Dial Transplant. 2023;38(4):1027–40.
doi: 10.1093/ndt/gfac165 pubmed: 35974693
Bairey Merz CN, Dember LM, Ingelfinger JR, Vinson A, Neugarten J, Sandberg KL, et al. Sex and the kidneys: current understanding and research opportunities. Nat Rev Nephrol. 2019;15(12):776–83.
doi: 10.1038/s41581-019-0208-6 pubmed: 31586165
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.
doi: 10.1056/NEJMoa041031 pubmed: 15385656
Tanaka K, Watanabe T, Takeuchi A, Ohashi Y, Nitta K, Akizawa T, et al. Cardiovascular events and death in Japanese patients with chronic kidney disease. Kidney Int. 2017;91(1):227–34.
doi: 10.1016/j.kint.2016.09.015 pubmed: 27884399
Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580–91.
doi: 10.1056/NEJMoa0706245 pubmed: 18256393
Kanauchi N, Ookawara S, Ito K, Mogi S, Yoshida I, Kakei M, et al. Factors affecting the progression of renal dysfunction and the importance of salt restriction in patients with type 2 diabetic kidney disease. Clin Exp Nephrol. 2015;19(6):1120–6.
doi: 10.1007/s10157-015-1118-y pubmed: 25920730
Heerspink HL, Ritz E. Sodium chloride intake: Is lower always better? J Am Soc Nephrol. 2012;23(7):1136–9.
doi: 10.1681/ASN.2012010099 pubmed: 22677555
Rodríguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. American Journal of Physiology-Renal Physiology. 2004;286(4):F606–16.
doi: 10.1152/ajprenal.00269.2003 pubmed: 15001451
Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol. 2008;19(5):999–1007.
doi: 10.1681/ASN.2007060693 pubmed: 18272844 pmcid: 2386733
Shi H, Su X, Li C, Guo W, Wang L. Effect of a low-salt diet on chronic kidney disease outcomes: a systematic review and meta-analysis. BMJ Open. 2022;12(1): e050843.
doi: 10.1136/bmjopen-2021-050843 pubmed: 35017237 pmcid: 8753423
Yamagata K, Makino H, Akizawa T, Iseki K, Itoh S, Kimura K, et al. Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan. Clin Exp Nephrol. 2010;14(2):144–51.
doi: 10.1007/s10157-009-0249-4 pubmed: 20020312
Yamagata K, Makino H, Iseki K, Ito S, Kimura K, Kusano E, et al. Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial. PLoS ONE. 2016;11(3): e0151422.
doi: 10.1371/journal.pone.0151422 pubmed: 26999730 pmcid: 4801411
Imasawa T, Saito C, Kai H, Iseki K, Kazama JJ, Shibagaki Y, et al. Long-term effectiveness of a primary care practice facilitation program for chronic kidney disease management: an extended follow-up of a cluster-randomized FROM-J study. Nephrol Dial Transplant. 2023;38(1):158–66.
doi: 10.1093/ndt/gfac041 pubmed: 35195257
Iseki K, Yamagata K. A practical approach of salt and protein restriction for CKD patients in Japan. BMC Nephrol. 2016;17:87. https://doi.org/10.1186/s12882-016-0298-3 .
doi: 10.1186/s12882-016-0298-3 pubmed: 27430268 pmcid: 4949925
Kai H, Doi M, Okada M, Yamada K, Iwabe H, Saito C, Yamagata K. Evaluation of the validity of a Novel CKD assessment checklist used in the frontier of renal outcome modifications in Japan study. J Ren Nutr. 2016;26(5):334–40.
doi: 10.1053/j.jrn.2016.02.010 pubmed: 27085664
Yamagata K. Trends in the incidence of kidney replacement therapy: comparisons of ERA, USRDS and Japan registries. Nephrol Dial Transplant. 2023;38(4):797–9.
doi: 10.1093/ndt/gfac312 pubmed: 36441018
Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38–48.
doi: 10.4278/0890-1171-12.1.38 pubmed: 10170434
Kwasnicka D, Dombrowski SU, White M, Sniehotta F. Theoretical explanations for maintenance of behaviour change: a systematic review of behaviour theories. Health Psychol Rev. 2016;10(3):277–96.
doi: 10.1080/17437199.2016.1151372 pubmed: 26854092 pmcid: 4975085
Coggins CH, Breyer Lewis J, Caggiula AW, Castaldo LS, Klahr S, Wang SR. Differences between women and men with chronic renal disease. Nephrol Dial Transplant. 1998;13(6):1430–7.
doi: 10.1093/ndt/13.6.1430 pubmed: 9641172
Nielsen AB, de Fine ON, Gannik D, Hindsberger C, Hollnagel H. Structured personal diabetes care in primary health care affects only women’s HbA1c. Diabetes Care. 2006;29(5):963–9.
doi: 10.2337/dc05-1807 pubmed: 16644621
Yoshinaka M, Ikebe K, Uota M, Ogawa T, Okada T, Inomata C, et al. Age and sex differences in the taste sensitivity of young adult, young-old and old-old Japanese. Geriatr Gerontol Int. 2016;16(12):1281–8.
doi: 10.1111/ggi.12638 pubmed: 26493051
Barragan R, Coltell O, Portoles O, Asensio EM, Sorli JV, Ortega-Azorin C, et al. Bitter, sweet, salty, sour and umami taste perception decreases with age: sex-specific analysis, modulation by genetic variants and taste-preference associations in 18 to 80 year-old subjects. Nutrients. 2018;10(10):1539.
doi: 10.3390/nu10101539 pubmed: 30340375 pmcid: 6213100
Okubo R, Kondo M, Hoshi SL, Okada M, Doi M, Takahashi H, et al. Cost-effectiveness of behavior modification intervention for patients with chronic kidney disease in the FROM-J study. J Ren Nutr. 2021;31(5):484–93.
doi: 10.1053/j.jrn.2020.12.008 pubmed: 33744060
Okubo R, Kondo M, Hoshi SL, Kai H, Saito C, Iseki K, et al. Behaviour modification intervention for patients with chronic kidney disease could provide a mid- to long-term reduction in public health care expenditure: budget impact analysis. Clin Exp Nephrol. 2022;26(6):601–11.
doi: 10.1007/s10157-022-02185-1 pubmed: 35084644

Auteurs

Noriko Kanauchi (N)

Comprehensive Human Sciences Doctoral Program in Medical Sciences, University of Tsukuba, Tsukuba, Japan.
Tohto University, Chiba, Japan.

Chie Saito (C)

Department of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Kei Nagai (K)

Department of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Kohsuke Yamada (K)

Kamakura Women's University, Kamakura, Japan.

Hirayasu Kai (H)

Ibaraki Clinical Education and Training Center, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Ibaraki Prefectural Central Hospital, Kasama, Japan.

Tsuyoshi Watanabe (T)

Tokyo-Kita Medical Center, Tokyo, Japan.

Ichiei Narita (I)

Division of Clinical Nephrology and Rheumatology, Niigata Institute for Health and Sports Medicine, Niigata, Japan.

Seiichi Matsuo (S)

Tokai National Higher Education and Research System, Nagoya, Japan.

Hirofumi Makino (H)

Okayama University, Okayama, Japan.

Akira Hishida (A)

Yaizu City Hospital, Yaizu, Japan.

Kunihiro Yamagata (K)

Department of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan. k-yamaga@md.tsukuba.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH